Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia

BACKGROUND: Imatinib is a highly effective treatment for chronic myeloid leukemia (CML) that was approved by the Food and Drug Administration in 2001, and thereafter rapidly became front line therapy. This study characterized the prevailing chronic myeloid leukemia therapies in the United States and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Wiggins, Charles L., Harlan, Linda C., Nelson, Harold E., Stevens, Jennifer L., Willman, Cheryl L., Libby, Edward N., Hromas, Robert A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2010
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913144/
https://ncbi.nlm.nih.gov/pubmed/20670732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2010.03.018
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk